Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 4/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.55 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.55 |
| ▸ | ITGAL | P20701 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17244051 | 1.00 | MTNR1A (0.62) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL29429300 | 1.00 | MTNR1A (0.62) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL29640391 | 1.00 | MTNR1A (0.62) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL29674779 | 1.00 | MTNR1A (0.62) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL29429295 | 0.99 | MTNR1A (0.61) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL29674872 | 0.99 | MTNR1A (0.61) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL25264926 | 0.93 | MEN1 (0.64) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL25264480 | 0.93 | MEN1 (0.64) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL22206848 | 0.93 | MEN1 (0.64) | MTNR1AEPHX2ALOX15ACEPPARG | |
| SCHEMBL25183154 | 0.93 | MEN1 (0.64) | MTNR1AEPHX2ALOX15ACEPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114846108-B | Anti-pollution material | 日产化学株式会社 | 2024-08-20 | — | — | CN | disclosed |
| US-20240116979-A1 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | NISSAN CHEMICAL CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20240067675-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | NISSAN CHEMICAL CORPORATION (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | NISSAN CHEMICAL CORPORATION (JP) | 2023-12-21 | — | — | US | disclosed |
| EP-4265629-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | Nissan Chemical Corporation (JP) | 2023-10-25 | — | — | EP | disclosed |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | KYUSHU UNIVERSITY (JP) | 2023-10-03 | — | — | US | disclosed |
| CN-116744892-A | Compositions comprising a lipid peptide and a sucrose ester | 日产化学株式会社 | 2023-09-12 | — | — | CN | disclosed |
| CN-116648455-A | Method for preparing lipid peptide | 日产化学株式会社 | 2023-08-25 | — | — | CN | disclosed |
| EP-4230265-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | Nissan Chemical Corporation (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-116615435-A | Method for preparing lipid peptide | 日产化学株式会社 | 2023-08-18 | — | — | CN | disclosed |
| EP-3881823-B1 | SOLID BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND | NISSAN CHEMICAL CORP (JP) | 2023-01-25 | — | — | EP | disclosed |
| EP-4074380-A1 | ANTI-POLLUTION MATERIAL | Nissan Chemical Corporation (JP) | 2022-10-19 | — | — | EP | disclosed |
| US-11452688-B2 | Transdermally absorbable base material containing lipid peptide compound | KYUSHU UNIVERSITY (JP) | 2022-09-27 | — | — | US | disclosed |
| WO-2022168894-A1 | CLOTH OR PAPER ANTI-POLLUTION MATERIAL | 日産化学株式会社 | 2022-08-11 | — | — | WO | disclosed |
| CN-114846108-A | Anti-pollution material | 日产化学株式会社 | 2022-08-02 | — | — | CN | disclosed |
| WO-2022138953-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | 日産化学株式会社 | 2022-06-30 | — | — | WO | disclosed |
| WO-2022138957-A1 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | 日産化学株式会社 | 2022-06-30 | — | — | WO | disclosed |
| EP-4014958-A1 | COATING FILM-FORMING COMPOSITION | Nissan Chemical Corporation (JP) | 2022-06-22 | — | — | EP | disclosed |
| WO-2022092284-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | 日産化学株式会社 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022065433-A1 | COSMETIC FOR HAIR | 日産化学株式会社 | 2022-03-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230404888-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | CUTA, SCAMP3, SURF4 | MTNR1A 3397/4885EPHX2 3813/4885ALOX15 1770/4885 |
| US-20240067675-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | VIP, NGLY1, NPPA | MTNR1A 4257/4885EPHX2 2059/4885ALOX15 633/4885 |
| US-20240116979-A1 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | NPPA, VIP, NGLY1 | MTNR1A 3371/4885EPHX2 1672/4885ALOX15 314/4885 |
| US-11771645-B2 | Transdermally absorbable base material containing lipid peptide compound | NGLY1, NR1H4, HRH1 | MTNR1A 2165/4885EPHX2 1679/4885ALOX15 419/4885 |
| US-11452688-B2 | Transdermally absorbable base material containing lipid peptide compound | NGLY1, NR1H4, HRH1 | MTNR1A 2165/4885EPHX2 1679/4885ALOX15 419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.